The Capital Group Companies, Inc. - Net Worth and Insider Trading

The Capital Group Companies, Inc. Net Worth

The estimated net worth of The Capital Group Companies, Inc. is at least $233 Million dollars as of 2024-06-24. The Capital Group Companies, Inc. is the 2201 Interest of corporation controlled by you of CanSino Biologics Inc and owns about 11,577,388 shares of CanSino Biologics Inc (HKSE:06185) stock worth over $233 Million. Details can be seen in The Capital Group Companies, Inc.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that The Capital Group Companies, Inc. has not made any transactions after 2023-07-31 and currently still holds the listed stock(s).

Transaction Summary of The Capital Group Companies, Inc.

To

The Capital Group Companies, Inc. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, The Capital Group Companies, Inc. owns 1 companies in total, including CanSino Biologics Inc (HKSE:06185) .

Click here to see the complete history of The Capital Group Companies, Inc.’s form 4 insider trades.

Insider Ownership Summary of The Capital Group Companies, Inc.

Ticker Comapny Transaction Date Type of Owner
HKSE:06185 CanSino Biologics Inc 2023-07-31 2201 Interest of corporation controlled by you

The Capital Group Companies, Inc. Latest Holdings Summary

The Capital Group Companies, Inc. currently owns a total of 1 stock. The Capital Group Companies, Inc. owns 11,577,388 shares of CanSino Biologics Inc (HKSE:06185) as of July 31, 2023, with a value of $233 Million.

Latest Holdings of The Capital Group Companies, Inc.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:06185 CanSino Biologics Inc 2023-07-31 11,577,388 20.10 232,705,499

Holding Weightings of The Capital Group Companies, Inc.


The Capital Group Companies, Inc. Form 4 Trading Tracker

According to the SEC Form 4 filings, The Capital Group Companies, Inc. has made a total of 26 transactions in CanSino Biologics Inc (HKSE:06185) over the past 5 years, including 5 buys and 21 sells. The most-recent trade in CanSino Biologics Inc is the sale of 476,600 shares on July 31, 2023, which brought The Capital Group Companies, Inc. around $14 Million.

Insider Trading History of The Capital Group Companies, Inc.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

The Capital Group Companies, Inc. Trading Performance

GuruFocus tracks the stock performance after each of The Capital Group Companies, Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by The Capital Group Companies, Inc. is -46.93%. GuruFocus also compares The Capital Group Companies, Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by The Capital Group Companies, Inc. within 3 months outperforms 0 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how The Capital Group Companies, Inc.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of The Capital Group Companies, Inc.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -16.76 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -12.42 LIMIT LIMIT LIMIT LIMIT LIMIT

The Capital Group Companies, Inc. Ownership Network

Ownership Network List of The Capital Group Companies, Inc.

No Data

Ownership Network Relation of The Capital Group Companies, Inc.

Insider Network Chart

The Capital Group Companies, Inc. Owned Company Details

What does CanSino Biologics Inc do?

Who are the key executives at CanSino Biologics Inc?

The Capital Group Companies, Inc. is the 2201 Interest of corporation controlled by you of CanSino Biologics Inc. Other key executives at CanSino Biologics Inc include Jpmorgan Chase & Co. , Citigroup Inc. , and 2201 Interest of corporation controlled by you The Goldman Sachs Group, Inc. .

CanSino Biologics Inc (HKSE:06185) Insider Trades Summary

Over the past 18 months, The Capital Group Companies, Inc. made 17 insider transaction in CanSino Biologics Inc (HKSE:06185) with a net sale of 7,656,500. Other recent insider transactions involving CanSino Biologics Inc (HKSE:06185) include a net sale of 1,501,555 shares made by Jpmorgan Chase & Co. , a net sale of 0 shares made by Citigroup Inc. ,

In summary, during the past 3 months, insiders sold 0 shares of CanSino Biologics Inc (HKSE:06185) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,934,340 shares of CanSino Biologics Inc (HKSE:06185) were sold and 2,776,285 shares were bought by its insiders, resulting in a net sale of 9,158,055 shares.

CanSino Biologics Inc (HKSE:06185)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CanSino Biologics Inc Insider Transactions

No Available Data

The Capital Group Companies, Inc. Mailing Address

Above is the net worth, insider trading, and ownership report for The Capital Group Companies, Inc.. Currently GuruFocus does not have mailing address information for The Capital Group Companies, Inc..

Discussions on The Capital Group Companies, Inc.

No discussions yet.